New Risk • Apr 26
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.7% average weekly change). Earnings have declined by 22% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Market cap is less than US$100m (€16.4m market cap, or US$19.2m). Buy Or Sell Opportunity • Apr 21
Now 23% overvalued after recent price rise Over the last 90 days, the stock has risen 2.5% to €1.24. The fair value is estimated to be €1.00, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company has become profitable. Valuation Update With 7 Day Price Move • Apr 20
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to €1.17, the stock trades at a trailing P/E ratio of 34.6x. Average trailing P/E is 14x in the IT industry in Italy. Total loss to shareholders of 37% over the past three years. Aankondiging • Apr 14
Softlab S.p.A., Annual General Meeting, Jun 05, 2026 Softlab S.p.A., Annual General Meeting, Jun 05, 2026, at 11:00 W. Europe Standard Time. Valuation Update With 7 Day Price Move • Mar 25
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to €1.01, the stock trades at a trailing P/E ratio of 29.7x. Average trailing P/E is 15x in the IT industry in Italy. Total loss to shareholders of 48% over the past three years. Buy Or Sell Opportunity • Mar 21
Now 25% overvalued Over the last 90 days, the stock has fallen 1.6% to €1.25. The fair value is estimated to be €1.00, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company has become profitable. Buy Or Sell Opportunity • Feb 23
Now 20% overvalued Over the last 90 days, the stock has fallen 14% to €1.25. The fair value is estimated to be €1.03, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company has become profitable. Reported Earnings • Oct 12
First half 2025 earnings released: EPS: €0.033 (vs €0.01 loss in 1H 2024) First half 2025 results: EPS: €0.033 (up from €0.01 loss in 1H 2024). Revenue: €16.1m (up 21% from 1H 2024). Net income: €441.0k (up €577.2k from 1H 2024). Profit margin: 2.7% (up from net loss in 1H 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance. Reported Earnings • May 28
Full year 2024 earnings released Full year 2024 results: Revenue: €29.1m (up 10.0% from FY 2023). Net loss: €122.0k (loss narrowed 59% from FY 2023). New Risk • May 12
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Earnings have declined by 16% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Market cap is less than US$100m (€10.8m market cap, or US$12.2m). Buy Or Sell Opportunity • May 02
Now 22% overvalued Over the last 90 days, the stock has fallen 17% to €0.64. The fair value is estimated to be €0.52, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Meanwhile, the company became loss making. New Risk • Mar 20
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €9.22m (US$10.00m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.8% average weekly change). Earnings have declined by 16% per year over the past 5 years. Market cap is less than US$10m (€9.22m market cap, or US$10.00m). New Risk • Jan 16
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Italian stocks, typically moving 7.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.6% average weekly change). Earnings have declined by 16% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€11.0m market cap, or US$11.4m). Reported Earnings • Oct 25
First half 2024 earnings released: €0.01 loss per share (vs €0.10 profit in 1H 2023) First half 2024 results: €0.01 loss per share (down from €0.10 profit in 1H 2023). Revenue: €13.4m (up 8.6% from 1H 2023). Net loss: €136.0k (down 110% from profit in 1H 2023). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 30% per year, which means it has not declined as severely as earnings. New Risk • Oct 24
New major risk - Revenue and earnings growth Earnings have declined by 16% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.3% average weekly change). Earnings have declined by 16% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€13.7m market cap, or US$14.8m). Reported Earnings • May 30
Full year 2023 earnings released Full year 2023 results: Revenue: €26.5m (up 10% from FY 2022). Net loss: €297.0k (down 109% from profit in FY 2022). New Risk • Apr 19
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.1% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€16.7m market cap, or US$17.8m). Buy Or Sell Opportunity • Feb 08
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 15% to €1.63. The fair value is estimated to be €1.34, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.7% over the last year. Earnings per share has declined by 12%. Buy Or Sell Opportunity • Jan 24
Now 39% overvalued after recent price rise Over the last 90 days, the stock has risen 16% to €1.75. The fair value is estimated to be €1.26, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.7% over the last year. Earnings per share has declined by 12%. New Risk • Nov 06
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Italian stocks, typically moving 7.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (7.9% average weekly change). Minor Risk Market cap is less than US$100m (€21.3m market cap, or US$22.8m). Reported Earnings • Oct 06
First half 2023 earnings released: EPS: €0.10 (vs €0.098 in 1H 2022) First half 2023 results: EPS: €0.10 (up from €0.098 in 1H 2022). Revenue: €12.3m (up 3.1% from 1H 2022). Net income: €1.39m (up 5.6% from 1H 2022). Profit margin: 11% (in line with 1H 2022). New Risk • Jul 12
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (30% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (5.0% average weekly change). Market cap is less than US$100m (€22.5m market cap, or US$25.0m). Reported Earnings • Oct 03
First half 2022 earnings released: EPS: €0.10 (vs €0.04 in 1H 2021) First half 2022 results: EPS: €0.10 (up from €0.04 in 1H 2021). Revenue: €12.0m (up 50% from 1H 2021). Net income: €1.32m (up 143% from 1H 2021). Profit margin: 11% (up from 6.8% in 1H 2021). The increase in margin was driven by higher revenue.